Efficacy of a Combination of HBV RNA and HBeAg in Predicting HBeAg Seroconversion in Patients Treated with Entecavir for 144 Weeks - Xiaomei Wang, Zhongfeng Wang, Xiumei Chi, Ruihong Wu, Qinglong Jin, Hongqin Xu, Xiuzhu Gao, Lei Yu, Yuping Chen, Jia Shang, Longgen Liu, Shuqin Zhang, Yongfang Jiang, Mingxiang Zhang, Qiaoxia Tong - Dissemin

Language
Login

Published in

Elsevier, International Journal of Infectious Diseases, (99), p. 171-178, 2020

DOI: 10.1016/j.ijid.2020.07.031

Links

Elsevier

Tools

Export citation

Search in Google Scholar

Efficacy of a Combination of HBV RNA and HBeAg in Predicting HBeAg Seroconversion in Patients Treated with Entecavir for 144 Weeks

Journal article published in 2020 by Xiaomei Wang, Zhongfeng Wang, Xiumei Chi, Ruihong Wu, Qinglong Jin, Hongqin Xu, Xiuzhu Gao, Lei Yu, Yuping Chen, Jia Shang, Longgen Liu, Shuqin Zhang, Yongfang Jiang, Mingxiang Zhang, Qiaoxia Tong and other authors.

This paper is made freely available by the publisher.

This paper is made freely available by the publisher.

Full text: Download

Green circle

Preprint: archiving allowed

Upload

Green circle

Postprint: archiving allowed

Upload

Green circle

Published version: archiving allowed

Upload

Policy details

Data provided by

SHERPA/RoMEO